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Subcortical band heterotopia (SBH), also known as double cortex syndrome, is a
malformation of cortical development caused by inherited or somatic gene variants.
We present a case of a young adult with posterior SBH and electroclinical features of
focal neocortical temporal lobe epilepsy. Genomic blood analysis identified a pathogenic
somatic mosaicism duplication variant of the PAFAH1B1 gene. Despite bilateral cortical
MRI abnormalities, the interictal and ictal EEG findings indicated a focal epileptogenic
region in the left posterior temporal region. Chronic responsive cortical neurostimulation
across two four-contact depth electrodes placed 5 mm on either side of the maximal
interictal spiking identified during intraoperative electrocorticography resulted in a
consistent 28% reduction in duration of electrographic seizures and as well as constricted
propagation. Although electrographic seizures continued, the family reported no clinical
seizures and a marked improvement in resistant behaviors. This observation supports
that focal neocortical neuromodulation can control clinical seizures of consistently
localized origin despite genetic etiology, bilateral structural brain abnormalities, and
continuation of non-propagating electrographic seizures. We propose that a secondary
somatic mutation may be the cause of the focal neocortical temporal lobe epilepsy.
Keywords: band heterotopia, LIS1 gene, temporal lobe epilepsy, responsive neurostimulation (RNS), PAFAH1B1

Subcortical band heterotopia (SBH), also known as double cortex syndrome, is a malformation
of cortical development that is associated with cognitive problems and seizures (1). The most
common causal mutations occur on the DCX gene (protein doublecortin) at Xq22.3–q23 (2). More
prominent posterior heterotopia are seen on MRI in persons with a mosaic pathogenic mutation
of the platelet-activating factor acetylhydrolase 1B1 [PAFAH1B1; also known as LIS1 (3)] gene (4).
We present a 32 year old patient with posterior SBH (Figures 1A,B) and a pathogenic somatic
mosaicism duplication variant of the PAFAH1B1 gene (c. 162dupA; p. Trp55MetfsX6; GeneDx,

1

November 2021 | Volume 12 | Article 779113

Gilliam et al.

Double Cortex and TLE

FIGURE 2 | (A) Typical seizure recorded from chronic intracortical electrodes
prior to activating stimulation and (B) The typical shortened seizure with less
propagation following optimization of stimulation parameters.

FIGURE 1 | (A) T2-weighted axial MRI of bilateral posterior band heterotopia
(white arrows), (B) T1-weighted coronal MRI, and (C) scalp interictal EEG with
left posterior temporal spikes (black arrow).

localize the epileptogenic region. The neurosurgeon (M.S.)
performed a craniotomy large enough to allow several
centimeters of cortical EEG recording around the predicted
epileptogenic region based on the T5 maximal interictal EEG
spikes. Intraoperative electrocorticography during 25 min
of recording from a depth electrode sequentially placed at
3–5 mm increments targeting both layers of cortex across
the epileptogenic region identified a single, discrete region
of maximal spike amplitude. The two depth electrodes for
responsive neurostimulation had four contacts each at 3.5 mm
intercontact spacing, and were placed 5 mm on either side of the
maximal spike negativity identified during electrocorticography.
The depth of each electrode was calculated based on MRI
measurements to allow two contacts in each layer of the
double cortex.
Following 1 month of baseline observation, stimulation
intensity was gradually increased by 0.5–1 mA at 2- to 4-week
intervals. The final stimulation pathway was 5 mA across anodal
contacts on one electrode to cathodal contacts on the other
(charge density 2.5 µC/Cm2 , pulse width 160 µS, duration
100 ms, and frequency 200 Hz). Her family reported a gradual
decline in the intensity and duration of the clinical seizures,
until they no longer observed any behaviors suspicious for
seizures. The family emphasized cessation of postictal irritability
and depression. She also began participating in family activities
such as cooking and singing. This clinical improvement was
associated with decreased electrographic seizure duration from
a mean of 25–18 s (median 23 and 17 s; Wilcoxon twosample test p-value <0.001) and less propagation, as shown in
Figures 2A,B. Her electrographic seizure rate did not decrease.
No electrographic seizures over 19 s, and no clinical seizures,
were observed for a follow-up period of 18 months. No changes

Inc., Gaithersburg, MD). She had a moderate static
encephalopathy with limited vocabulary and fund of knowledge,
but was able to express herself clearly. No family members had
epilepsy or genetic disorder, supporting a de novo mutation. Her
epilepsy was diagnosed at age 20 months. The seizures consisted
of staring, unresponsiveness, and downward head turning to the
left lasting up to 30 s. She remained irritable and depressed for
many hours afterward. The seizures recurred at a rate of up to
several per day, several days per week. Seven medications during
30 years of treatment had not controlled the focal seizures with
impaired awareness. She had several generalized tonic clonic
(GTC) seizures per year throughout adulthood, but these stopped
after the addition of zonisamide to lamotrigine. Interictal scalp
EEG showed frequent spike and slow wave complexes in the left
posterior temporal region, maximal at the T5 (P7) electrode as
shown in Figure 1C. Seizure onset consisted of low amplitude
fast (beta) activity in same electrode.
After extensive discussion of treatment options, she and her
family elected responsive cortical neurostimulation (Neuropace
RNS R , Mountain View, CA). Following their review of the
published efficacy data on vagal nerve stimulation and anterior
thalamic nucleus stimulation, her parents concluded that
responsive cortical stimulation was their preferred option. Also,
anterior thalamic stimulation was not yet commercially available.
Based on the highly focal and concordant interictal and ictal
EEG findings, and frequency of the discrete interictal spikes
every 1–5 s (Figure 1C), the clinical epilepsy team concluded
that intraoperative electrocorticography was adequate to
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were made to the doses of lamotrigine and zonisamide following
RNS implantation.
Focal resection was reported to improve three of eight
patients with SBH and evidence of a focal epileptogenic region,
but the authors concluded that their results did not support
the use of focal surgical resection (5). To our knowledge
this is the first reported case of SBH to receive responsive
focal neurostimulation, which resulted in cessation of clinical
seizures as the mean duration of electrographic seizures
decreased by 28%. Similar to tuberous sclerosis complex with
a genetic etiology and multiple tubers, SBH patients may
have consistently focal onset that responds to focal treatment
(6). We speculate that focal epilepsy in SBH patients may
be due to “second hit” somatic mutations, analogous to the
formation of tubers in tuberous sclerosis (7). Our case also
supports proof of principle that shortening seizure duration
and propagation with responsive neurostimulation can eliminate
clinical seizures.
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